- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray gets NASDAQ small-cap listing
The stock of x-ray digitization firm Swissray International hasbeen approved for listing on the NASDAQ stock exchange's small-capbulletin board under the symbol SRMI. Swissray, of Hitzkirch,Switzerland, is developing Add-On Bucky, a device that
The stock of x-ray digitization firm Swissray International has
been approved for listing on the NASDAQ stock exchange's small-cap
bulletin board under the symbol SRMI. Swissray, of Hitzkirch,
Switzerland, is developing Add-On Bucky, a device that retrofits
to conventional x-ray systems for x-ray digitization (SCAN 12/13/95).
Swissray's stock was trading at about $4.75 a share last week.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
